Invention Grant
- Patent Title: Aurora kinase inhibitors for inhibiting mitotic progression
-
Application No.: US13217729Application Date: 2011-08-25
-
Publication No.: US09988384B2Publication Date: 2018-06-05
- Inventor: Christopher F. Claiborne , Todd B. Sells , Stephen G. Stroud
- Applicant: Christopher F. Claiborne , Todd B. Sells , Stephen G. Stroud
- Applicant Address: US MA Cambridge
- Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- Agent Kristen C. Buteau
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides potent inhibitors of Aurora A kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.
Public/Granted literature
- US20110312943A1 AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION Public/Granted day:2011-12-22
Information query
